Tour de France 2026 Injury Report: Carapaz Returns as Van Aert and Tarling Face Setbacks

The countdown to the 2026 Tour de France has entered its most critical—and perilous—phase, with the peloton navigating the traditional June preparation races under immense pressure. As riders push their bodies to the absolute limit to secure their spots on the starting line in Barcelona, team doctors and sports directors are working overtime to manage a sudden, disruptive spike in high-profile injuries. While some general classification contenders are finally finding their rhythm and recovering from early-season setbacks, others are facing agonizing, last-minute medical emergencies that threaten to completely derail their July ambitions. The contrast between successful rehabilitations and sudden crashes highlights the razor-thin margins of professional cycling, where a single slick corner or lingering infection can alter a team's entire summer strategy.[1][3]

The most uplifting news of the preparation window comes from the EF Education-EasyPost camp, where Olympic champion Richard Carapaz is finally making his long-awaited return to the professional peloton. The Ecuadorian star was forced to completely abandon his spring campaign and miss the Giro d'Italia after undergoing surgery in April to remove a perineal cyst. The operation required a delicate and frustratingly slow rehabilitation process, keeping him off the bike during crucial training blocks. However, after months of quiet recovery at home, Carapaz has been cleared to race, bringing a massive morale boost to his squad as they finalize their Tour de France roster.[1]

Carapaz is officially back in action, using the GP Gippingen and the grueling stages of the Tour de Suisse to rigorously test his legs against WorldTour competition. "Right now, I feel good on the bike," Carapaz stated through his team, noting that his extended time at home allowed him to build a stable, uninterrupted training rhythm without the constant travel of the racing circuit. His return to the mountains of Switzerland serves as the ultimate proving ground; if his power numbers and recovery metrics hold up over the multi-day stage race, he will head to the Tour de France as a formidable wild card in the high mountains.[1]

However, the optimistic mood surrounding Carapaz is markedly absent at Visma | Lease a Bike, which is currently grappling with a mounting medical crisis that threatens their Tour dominance. Wout van Aert, the versatile Belgian superstar, had just claimed his first road victory since Paris-Roubaix by winning a chaotic sprint on stage 5 of the Tour Auvergne-Rhône-Alpes. The victory seemed to signal a triumphant return to form, but the celebration was incredibly short-lived. The very next morning, team management announced that Van Aert was forced to abandon the race entirely, citing severe, escalating pain in his elbow.[4][6]

Van Aert had been quietly nursing a deep elbow wound sustained in a high-speed training crash on June 1. While the initial damage appeared manageable—allowing him to start the preparation race with visible strapping on his arm and knee—team director Maarten Wynants revealed that the wound suddenly worsened overnight and completely stopped healing. Visma's medical staff attempted to aggressively reduce the swelling with ice and compression therapies, but the treatments failed to bring enough improvement for the Belgian to safely grip the handlebars and continue racing.[4]

Subsequent medical examinations at a hospital in Belgium confirmed the team's worst fears: the elbow wound had become severely infected. According to inside reports and team management, the irritation was drastically aggravated by Van Aert's aerodynamic position on the time-trial bars during the race's team time trial. The intense pressure placed directly on the forearms and elbows in the aggressive aero tuck forced bacteria deeper into the unhealed tissue, triggering a severe inflammatory response that required immediate medical intervention and a total cessation of physical exertion.[2]

This infection has forced Van Aert into a total stoppage of all training activities, throwing his carefully calibrated summer schedule into complete disarray. The mandatory rest period casts serious doubt on his ability to participate in the team's upcoming, highly crucial high-altitude training camp in Tignes. More alarmingly, it puts his actual start at the Tour de France in jeopardy. Without the necessary altitude adaptations and final endurance blocks, Van Aert may not possess the deep fitness required to survive three weeks of relentless racing, leaving Visma's leadership with a massive tactical void.[2][6]

Visma | Lease a Bike's roster woes unfortunately do not end with Van Aert's infected elbow. The powerhouse squad was already reeling from the devastating loss of Christophe Laporte, another vital engine for their flat and rolling stage strategies. Laporte has officially shifted his focus away from the Tour de France entirely in order to fully recover from a severe quadriceps tear, which he sustained in a separate, brutal training crash earlier in the spring. These compounding medical absences have decimated the team's depth, leaving the squad with a shocking four active riders by the final stage of the Auvergne-Rhône-Alpes race.[3][6]

Elsewhere in the peloton, the Ineos Grenadiers suffered a heartbreaking blow when their time-trial prodigy, Josh Tarling, crashed heavily on a treacherous mountain descent. The young British rider, who had impressively infiltrated the day's major breakaway on the opening mountain stage of the Tour Auvergne-Rhône-Alpes, lost control with just under 100 kilometers remaining. Television cameras captured Tarling sitting on the tarmac, visibly in agony and clutching his left arm against his chest—a classic, undeniable indicator of a broken collarbone in professional cycling.[3]

Medical scans at a local hospital quickly confirmed the collarbone fracture, requiring Tarling to undergo immediate surgery to stabilize the bone with plates and screws. The severe injury effectively rules the young powerhouse out of what would have been a highly anticipated Tour de France debut. His absence strips the Ineos Grenadiers of a crucial, massive engine for the flat transitional stages and removes one of the absolute top favorites for the Tour's individual time trials, forcing the British squad to completely rethink their roster composition.[3]

Meanwhile, the Decathlon CMA CGM squad faced a terrifying scare with their 19-year-old French prodigy, Paul Seixas. While navigating a highly technical and steep descent, Seixas lost control of his bike at a blistering 70 kilometers per hour. The teenager slid for up to 30 meters across the unforgiving tarmac, suffering severe abrasions across his hands, arms, and legs. Remarkably, his teammates helped him remount and chase the peloton for 60 kilometers, allowing him to finish the stage just over a minute behind the leaders in a stunning display of grit.[5]

Despite Seixas's bravery, team manager Julien Jurdie ultimately made the executive decision to pull the battered teenager from the race the following morning. Acknowledging that the soreness and stiffness had set in overnight, the team prioritized caution over immediate results. The withdrawal was a strictly preventative measure, designed to protect the young rider's long-term physical condition and ensure he can fully heal ahead of his highly anticipated Tour de France debut next month. In a sport defined by suffering, the decision highlighted a modern, health-first approach to rider management.[5]